Search Results - "Giedraitienė, Nataša"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Chronotypes and their relationship with depression, anxiety, and fatigue among patients with multiple sclerosis in Vilnius, Lithuania by Jonušaitė, Ieva, Sakalauskaitė-Juodeikienė, Eglė, Kizlaitienė, Rasa, Giedraitienė, Nataša, Sereikė, Ieva, Liutkienė, Justina, Kaubrys, Gintaras, Jatužis, Dalius

    Published in Frontiers in neurology (27-11-2023)
    “…Approximately half of patients with multiple sclerosis (PWMS) experience sleep disorders or changes in the circadian rhythm, that may further promote the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration by Giedraitienė, Nataša, Kizlaitienė, Rasa, Kaubrys, Gintaras

    Published in Medical science monitor (10-12-2015)
    “…BACKGROUND Assessment of cognitive impairment (CI) in multiple sclerosis (MS) patients is very useful, but it requires time-consuming expert evaluation with…”
    Get full text
    Journal Article
  4. 4

    Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests by Giedraitiene, Natasa, Kaubrys, Gintaras

    Published in Frontiers in neurology (04-06-2019)
    “…Cognition may be affected at least as seriously as physical function during multiple sclerosis (MS) relapse, however MS relapse related cognitive disorders are…”
    Get full text
    Journal Article
  5. 5

    Seroprevalence of neuronal antibodies in diseases mimicking autoimmune encephalitis by Vaisvilas, Mantas, Petrosian, David, Bagdonaite, Loreta, Taluntiene, Vera, Kralikiene, Viktorija, Daugelaviciene, Neringa, Neniskyte, Urte, Kaubrys, Gintaras, Giedraitiene, Natasa

    Published in Scientific reports (04-03-2024)
    “…Detection of neuronal antibodies for autoimmune encephalitis and paraneoplastic neurological syndromes relies on commercially available cell-based assays and…”
    Get full text
    Journal Article
  6. 6

    Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study by Giedraitiene, Natasa, Drukteiniene, Egle, Kizlaitiene, Rasa, Cimbalas, Andrius, Asoklis, Rimvydas, Kaubrys, Gintaras

    Published in Frontiers in neurology (13-07-2021)
    “…Background: Brain atrophy, which is associated with cognitive impairment and retinal nerve fiber layer (RNFL) atrophy, is the main biomarker of…”
    Get full text
    Journal Article
  7. 7

    Tumefactive demyelinating disorders as stroke mimics: Description of cases and systematic review of the literature by Vaišvilas, Mantas, Vilionskis, Aleksandras, Sasnauskaitė, Indrė, Petrosian, David, Mickevičiūtė, Eitvilė, Giedraitienė, Nataša

    Published in Multiple sclerosis and related disorders (01-08-2023)
    “…tumefactive multiple sclerosis (TmMS) is a rare subtype of a demyelinating disease that develops over time. Cases of hyperacute presentations mimicking…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Composite Marker of Cognitive Dysfunction and Brain Atrophy is Highly Accurate in Discriminating Between Relapsing-Remitting and Secondary Progressive Multiple Sclerosis by Kizlaitienė, Rasa, Kaubrys, Gintaras, Giedraitienė, Nataša, Ramanauskas, Naglis, Dementavičienė, Jūratė

    Published in Medical science monitor (01-02-2017)
    “…BACKGROUND With the advent of numerous new-generation disease-modifying drugs for multiple sclerosis (MS), the discrimination between relapsing-remitting MS…”
    Get full text
    Journal Article
  10. 10

    Cognition During and After Multiple Sclerosis Relapse as Assessed With the Brief International Cognitive Assessment for Multiple Sclerosis by Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa

    Published in Scientific reports (25-05-2018)
    “…There is some evidence that cognition may be impaired during multiple sclerosis (MS) relapse. The aims of this study were to assess the cognitive status with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability by Vaisvilas, Mantas, Kaubrys, Gintaras, Kizlaitiene, Rasa, Taluntiene, Vera, Giedraitiene, Natasa

    Published in Multiple sclerosis and related disorders (01-12-2023)
    “…•Fewer relapses are established after HSCT than ATZ treatment.•ATZ may halt disability progression early in the course of highly active RMS.•After HSCT gradual…”
    Get full text
    Journal Article
  13. 13

    Therapeutic Plasma Exchange in Multiple Sclerosis Patients with Abolished Interferon-beta Bioavailability by Giedraitiene, Natasa, Kaubrys, Gintaras, Kizlaitiene, Rasa, Bagdonaite, Loreta, Griskevicius, Laimonas, Valceckiene, Vilma, Stoskus, Mindaugas

    Published in Medical science monitor (26-05-2015)
    “…Neutralizing antibodies (NAb) to interferon-beta (IFN-β) are associated with reduced bioactivity and efficacy of IFN-β in multiple sclerosis (MS). The…”
    Get full text
    Journal Article